Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feru-guard (Ferulic Acid and Angelica Archangelica Extract) for Behavioral Symptoms in Dementia

NCT03451760 is registered in ClinicalTrials.gov with Glovia Co., Ltd. as lead sponsor.

NCT NCT03451760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03451760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feru-guard (Ferulic Acid and Angelica Archangelica Extract) for Behavioral Symptoms in Dementia
Lead sponsor
Glovia Co., Ltd.
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2018
Completion date
December 31, 2019
Enrollment
70 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

behavioral and psychiatric symptoms of dementia